Literature DB >> 7783413

Treatment of malnourished CAPD patients with an amino acid based dialysate.

J D Kopple1, D Bernard, J Messana, R Swartz, J Bergström, B Lindholm, V Lim, G Brunori, M Leiserowitz, D M Bier.   

Abstract

Nineteen malnourished chronic peritoneal dialysis patients who were ingesting a low protein intake underwent metabolic balance studies to test whether a dialysate that contained amino acids would improve their protein nutrition. Patients lived in the hospital for 35 days while they ate a constant diet and underwent their usual regimen of continuous ambulatory peritoneal dialysis (CAPD). The first 15 days served as a Baseline Phase. For the last 20 days, the usual dialysate was substituted with a dialysate of essentially the same composition except that it contained 1.1% essential and nonessential amino acids and no glucose. Patients received one or two dialysate exchanges with amino acids each day depending on the amount necessary to bring the individual's dietary protein plus dialysate amino acid intake to 1.1 to 1.3 g/kg body weight/day. During Baseline, patients were in neutral nitrogen balance; net protein anabolism was positive, as determined from 15N-glycine studies. After commencing intraperitoneal amino acid therapy, nitrogen balance became significantly positive, there was a significant increase in net protein anabolism, the fasting morning plasma amino acid pattern became more normal, and serum total protein and transferrin concentrations rose. Patients generally tolerated the treatment well, although some patients developed mild metabolic acidemia. These findings indicate that a dialysate containing amino acids may improve protein malnutrition in CAPD patients ingesting low protein intakes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783413     DOI: 10.1038/ki.1995.164

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

Review 1.  New peritoneal dialysis fluids: practical use for children.

Authors:  Cornelis H Schröder
Journal:  Pediatr Nephrol       Date:  2003-11       Impact factor: 3.714

Review 2.  Nutrition in patients on peritoneal dialysis.

Authors:  Seung-Hyeok Han; Dae-Suk Han
Journal:  Nat Rev Nephrol       Date:  2012-02-07       Impact factor: 28.314

Review 3.  Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions.

Authors:  Ahad Qayyum; Elizabeth Ley Oei; Klara Paudel; Stanley L Fan
Journal:  World J Nephrol       Date:  2015-02-06

4.  Hyperbranched polyglycerol: a future alternative to polyglucose in peritoneal dialysis fluids?

Authors:  Bengt Rippe
Journal:  Perit Dial Int       Date:  2013 Jan-Feb       Impact factor: 1.756

Review 5.  A review of quality of life in chronic renal failure.

Authors:  D S Parsons; D C Harris
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

6.  Does low peritoneal glucose load protect from the development of left ventricular hypertrophy in peritoneal dialysis patients?

Authors:  Kamal Hassan; Fadi Hassan; Dunia Hassan; Saab Anwar; Hassan Shadi
Journal:  Clin Exp Nephrol       Date:  2015-11-22       Impact factor: 2.801

7.  Interference of peritoneal dialysis fluids with cell cycle mechanisms.

Authors:  Janine Büchel; Maria Bartosova; Gwendolyn Eich; Timo Wittenberger; Ludger Klein-Hitpass; Sonja Steppan; Thilo Hackert; Franz Schaefer; Jutta Passlick-Deetjen; Claus P Schmitt
Journal:  Perit Dial Int       Date:  2014-07-31       Impact factor: 1.756

8.  Nutrition support for the chronically wasted or acutely catabolic chronic kidney disease patient.

Authors:  T Alp Ikizler
Journal:  Semin Nephrol       Date:  2009-01       Impact factor: 5.299

9.  Dialysate as food as an option for automated peritoneal dialysis.

Authors:  Hoey L Tjiong; Roel Swart; Jacobus W Van den Berg; Marien W Fieren
Journal:  NDT Plus       Date:  2008-10

10.  Fat tissue and inflammation in patients undergoing peritoneal dialysis.

Authors:  Abraham Rincón Bello; Laura Bucalo; Soraya Abad Estébanez; Almudena Vega Martínez; Daniel Barraca Núñez; Claudia Yuste Lozano; Ana Pérez de José; Juan M López-Gómez
Journal:  Clin Kidney J       Date:  2016-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.